Cargando…
Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34)
For efficient intranasal transport of parathyroid hormone (1-34) [PTH(1-34)], there is a great medical need to investigate permeation enhancers for intranasal formulations. In this study, the development of PTH(1-34) intranasal formulations was conducted. Based on conformation and chemical stability...
Autores principales: | Wang, Dan, Du, Yimeng, Zhang, Wenpeng, Han, Xiaolu, Zhang, Hui, Wang, Zengming, Liu, Nan, Li, Meng, Gao, Xiang, Zhuang, Xiaomei, Gao, Jing, Zheng, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935113/ https://www.ncbi.nlm.nih.gov/pubmed/33657948 http://dx.doi.org/10.1080/10717544.2021.1889718 |
Ejemplares similares
-
Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier
por: Gao, Xiaoyi, et al.
Publicado: (2021) -
Comparison of Paliperidone Palmitate from Different Crystallization Processes and Effect on Formulations In Vitro and In Vivo
por: Shi, Junfeng, et al.
Publicado: (2022) -
Taste Masking Study Based on an Electronic Tongue: the Formulation Design of 3D Printed Levetiracetam Instant-Dissolving Tablets
por: Wang, Zengming, et al.
Publicado: (2021) -
3D Printing Technology Based on Versatile Gelatin-Carrageenan Gel System for Drug Formulations
por: Liang, En, et al.
Publicado: (2023) -
Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation
por: Osagie-Clouard, L., et al.
Publicado: (2017)